Clinical Trial Update: A Study of MRG002 in Treatment of Advanced HER-2 Positive Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for MRG002 in advanced HER-2 positive breast cancer with liver metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer with Liver Metastases

Drugs mentioned

• MRG002

Snippet

Sponsor: Shanghai Miracogen Inc. | Conditions: Breast Cancer With Liver Metastases | Phase 2 | Status: UNKNOWN